These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 19925904)

  • 21. Intestinal colonisation-inhibition and virulence of Salmonella phoP, rpoS and ompC deletion mutants in chickens.
    Methner U; Barrow PA; Gregorova D; Rychlik I
    Vet Microbiol; 2004 Jan; 98(1):37-43. PubMed ID: 14738780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deletion of the gene encoding the glycolytic enzyme triosephosphate isomerase (tpi) alters morphology of Salmonella enterica serovar Typhimurium and decreases fitness in mice.
    Paterson GK; Cone DB; Northen H; Peters SE; Maskell DJ
    FEMS Microbiol Lett; 2009 May; 294(1):45-51. PubMed ID: 19493007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective Immunity Elicited by Oral Immunization of Mice with
    Erova TE; Kirtley ML; Fitts EC; Ponnusamy D; Baze WB; Andersson JA; Cong Y; Tiner BL; Sha J; Chopra AK
    Front Cell Infect Microbiol; 2016; 6():148. PubMed ID: 27891321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunological responses induced by asd and wzy/asd mutant strains of Salmonella enterica serovar Typhimurium in BALB/c mice.
    Piao HH; Tam VT; Na HS; Kim HJ; Ryu PY; Kim SY; Rhee JH; Choy HE; Kim SW; Hong Y
    J Microbiol; 2010 Aug; 48(4):486-95. PubMed ID: 20799091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Refined live attenuated Salmonella enterica serovar Typhimurium and Enteritidis vaccines mediate homologous and heterologous serogroup protection in mice.
    Tennant SM; Schmidlein P; Simon R; Pasetti MF; Galen JE; Levine MM
    Infect Immun; 2015 Dec; 83(12):4504-12. PubMed ID: 26351285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunological characterization of a gidA mutant strain of Salmonella for potential use in a live-attenuated vaccine.
    Shippy DC; Fadl AA
    BMC Microbiol; 2012 Nov; 12():286. PubMed ID: 23194372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Virulent Salmonella enterica infections can be exacerbated by concomitant infection of the host with a live attenuated S. enterica vaccine via Toll-like receptor 4-dependent interleukin-10 production with the involvement of both TRIF and MyD88.
    Foster GL; Barr TA; Grant AJ; McKinley TJ; Bryant CE; MacDonald A; Gray D; Yamamoto M; Akira S; Maskell DJ; Mastroeni P
    Immunology; 2008 Aug; 124(4):469-79. PubMed ID: 18217948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deletion of an immune evasion gene,
    Allen JC; Natta SS; Nasrin S; Toapanta FR; Tennant SM
    Front Immunol; 2024; 15():1376734. PubMed ID: 38911854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An attenuated Salmonella enterica serovar Typhimurium strain lacking the ZnuABC transporter induces protection in a mouse intestinal model of Salmonella infection.
    Pesciaroli M; Aloisio F; Ammendola S; Pistoia C; Petrucci P; Tarantino M; Francia M; Battistoni A; Pasquali P
    Vaccine; 2011 Feb; 29(9):1783-90. PubMed ID: 21219981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Salmonella flagellin is not a dominant protective antigen in oral immunization with attenuated live vaccine strains.
    Kodama C; Matsui H
    Infect Immun; 2004 Apr; 72(4):2449-51. PubMed ID: 15039380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effective mucosal live attenuated Salmonella vaccine by deleting phosphotransferase system component genes ptsI and crr.
    Zhi Y; Lin SM; Jang AY; Ahn KB; Ji HJ; Guo HC; Lim S; Seo HS
    J Microbiol; 2019 Jan; 57(1):64-73. PubMed ID: 30552632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IFNγ expression by an attenuated strain of Salmonella enterica serovar Typhimurium improves vaccine efficacy in susceptible TLR4-defective C3H/HeJ mice.
    Al-Ojali SM; Tara Moore CB; Fernandez-Cabezudo MJ; Al-Ramadi BK
    Med Microbiol Immunol; 2013 Feb; 202(1):49-61. PubMed ID: 22684724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mouse models for assessing the cross-protective efficacy of oral non-typhoidal Salmonella vaccine candidates harbouring in-frame deletions of the ATP-dependent protease lon and other genes.
    Matsui H; Fukiya S; Kodama-Akaboshi C; Eguchi M; Yamamoto T
    J Med Microbiol; 2015 Mar; 64(Pt 3):295-302. PubMed ID: 25589672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of Salmonella enterica serovar Typhimurium TTSS-2 deficient fur mutant as safe live-attenuated vaccine candidate for immunocompromised mice.
    Vishwakarma V; Pati NB; Chandel HS; Sahoo SS; Saha B; Suar M
    PLoS One; 2012; 7(12):e52043. PubMed ID: 23284865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Salmonella enterica serovar Typhimurium ruvB mutant can confer protection against salmonellosis in mice.
    Choi J; Shin D; Ryu S
    Vaccine; 2010 Sep; 28(39):6436-44. PubMed ID: 20670908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulated delayed expression of rfaH in an attenuated Salmonella enterica serovar typhimurium vaccine enhances immunogenicity of outer membrane proteins and a heterologous antigen.
    Kong Q; Liu Q; Roland KL; Curtiss R
    Infect Immun; 2009 Dec; 77(12):5572-82. PubMed ID: 19805538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulated delayed synthesis of lipopolysaccharide and enterobacterial common antigen of Salmonella Typhimurium enhances immunogenicity and cross-protective efficacy against heterologous Salmonella challenge.
    Huang C; Liu Q; Luo Y; Li P; Liu Q; Kong Q
    Vaccine; 2016 Aug; 34(36):4285-92. PubMed ID: 27423383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the Salmonella enterica Serovar Pullorum Pathogenicity Island 2 Mutant as a Candidate Live Attenuated Oral Vaccine.
    Yin J; Cheng Z; Wang X; Xu L; Li Q; Geng S; Jiao X
    Clin Vaccine Immunol; 2015 Jul; 22(7):706-10. PubMed ID: 25924763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Attenuating gene expression (AGE) for vaccine development.
    Pascual DW; Suo Z; Cao L; Avci R; Yang X
    Virulence; 2013 Jul; 4(5):384-90. PubMed ID: 23652809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protection and immune responses induced by attenuated Salmonella typhimurium UK-1 strains.
    Zhang X; Kelly SM; Bollen W; Curtiss R
    Microb Pathog; 1999 Mar; 26(3):121-30. PubMed ID: 10089152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.